Suven Pharmaceuticals Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 249.49 | 240.04 | 260.39 |
| Operating Expense | 135.05 | 139.05 | 171.38 |
| Net Profit | 76.33 | 65.07 | 53.43 |
| Net Profit Margin | 30.59 | 27.11 | 20.52 |
| Earning Per Share | 3 | 2.56 | 2.10 |
| EBIDTA | 118 | 98.69 | 90.07 |
| Effective Tax Rate | 24.39 | 19.82 | 21.00 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 249.49 |
| Operating Expense | 135.05 |
| Net Profit | 76.33 |
| Net Profit Margin | 30.59 |
| Earning Per Share | 3.00 |
| EBIDTA | 118.00 |
| Effective Tax Rate | 24.39 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,024.99 | 1,330.08 | 1,320.22 |
| Operating Expenses Annual | 615.09 | 739.39 | 740.23 |
| Operating Profit Annual | 464.99 | 635.24 | 767.78 |
| Interest Annual | 7.43 | 12.75 | 6.23 |
| Depreciation | 48.29 | 42.70 | 38.71 |
| Net Profit Annual | 304.82 | 432.60 | 558.10 |
| Tax Annual | 103.96 | 146.79 | 164.35 |
| Particulars | Mar 2024 |
|---|---|
| Total Revenue Annual | 1,024.99 |
| Operating Expenses Annual | 615.09 |
| Operating Profit Annual | 464.99 |
| Interest Annual | 7.43 |
| Depreciation | 48.29 |
| Net Profit Annual | 304.82 |
| Tax Annual | 103.96 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 43.02 | 30.21 | 7.09 |
| Cash Flow from Operations | 370.65 | 492.82 | 269.89 |
| Cash Flow from Investing | -381.58 | -236.86 | -90.36 |
| Cash Flow from Financing | -13.78 | -243.14 | -156.41 |
| Cash Flow at the End | 18.31 | 43.02 | 30.21 |
| Particulars | Mar 2024 |
|---|---|
| Cash Flow at the Beginning | 43.02 |
| Cash Flow from Operations | 370.65 |
| Cash Flow from Investing | -381.58 |
| Cash Flow from Financing | -13.78 |
| Cash Flow at the End | 18.31 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 41.10 | 47.76 | 58.33 |
| PBIT Margin (%) | 36.34 | 44.52 | 55.37 |
| PBT Margin (%) | 31.45 | 41.03 | 48.88 |
| Net PROFIT Margin (%) | 29.74 | 32.52 | 42.27 |
| Return On Networth / Equity (%) | 14.31 | 26.46 | 43.17 |
| Return On Networth /Employed (%) | 18.82 | 34.28 | 51.45 |
| Return On Assets (%) | 15.46 | 25.04 | 39.31 |
| Total Debt / Equity (X) | 0.04 | 0.05 | 0.09 |
| Asset Turnover Ratio (%) | 0.52 | 0.77 | 0.93 |
| Particulars | Mar 2024 |
|---|---|
| PBDIT Margin (%) | 41.10 |
| PBIT Margin (%) | 36.34 |
| PBT Margin (%) | 31.45 |
| Net PROFIT Margin (%) | 29.74 |
| Return On Networth / Equity (%) | 14.31 |
| Return On Networth /Employed (%) | 18.82 |
| Return On Assets (%) | 15.46 |
| Total Debt / Equity (X) | 0.04 |
| Asset Turnover Ratio (%) | 0.52 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|
| Fixed Assets Annual | 523.65 | 512.03 | 534.19 |
| Total Current Assets Annual | 1,209.55 | 955.12 | 1,108.96 |
| Non Current Assets Annual | 1,031.16 | 1,003.21 | 695.93 |
| Total Shareholders Funds Annual | 2,055.90 | 1,749.38 | 1,520.69 |
| Total Assets Annual | 2,240.72 | 1,958.33 | 1,804.89 |
| Particulars | Mar 2024 |
|---|---|
| Fixed Assets Annual | 523.65 |
| Total Current Assets Annual | 1,209.55 |
| Non Current Assets Annual | 1,031.16 |
| Total Shareholders Funds Annual | 2,055.90 |
| Total Assets Annual | 2,240.72 |
EPS (INR)
Expected
3.23
Reported
3.23
Surprise
0.00%
Jun 2024
EPS beaten by 0.00%
Mar 2024
EPS beaten by 0.00%
Dec 2023
EPS beaten by 0.00%
